Short Interest in Integrated BioPharma, Inc. (OTCMKTS:INBP) Expands By 2,500.0%

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,200 shares, a growth of 2,500.0% from the October 15th total of 200 shares. Based on an average daily volume of 51,200 shares, the days-to-cover ratio is currently 0.1 days.

Integrated BioPharma Trading Up 3.2 %

Shares of INBP opened at $0.32 on Thursday. The business’s 50 day moving average is $0.26 and its 200 day moving average is $0.23. The company has a market capitalization of $9.63 million, a PE ratio of 32.03 and a beta of 0.62. Integrated BioPharma has a 12-month low of $0.16 and a 12-month high of $0.35.

Integrated BioPharma (OTCMKTS:INBP) last released its quarterly earnings results on Friday, September 20th. The company reported $0.01 earnings per share for the quarter. Integrated BioPharma had a return on equity of 0.59% and a net margin of 0.22%. The business had revenue of $12.75 million during the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.